TSO3 Announces the Vote Results from its Annual Meeting of the Shareholders

QUEBEC CITY and MYRTLE BEACH, SC, May 8, 2019 /PRNewswire/ - TSO3 Inc. (TSX: TOS), ("TSO(3)" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, today announced that the nominees listed in the management proxy circular dated April 4, 2019, were elected as directors of TSO(3). In addition, all other proposals submitted by management were approved.

Election of Directors

Based on the proxies received and the votes on a show of hands, the following individuals were elected as directors of the Company until the next annual shareholders' meeting. Accordingly, the results are set out below:

                           
      Votes for 
     % for  
     Withheld   
     % withheld


       Name

    ---


       Sara Elford          24,502,253    94.57    1,407,129            5.43

    ---


       Martin J. Madden     24,219,590    93.48    1,689,792            6.52

    ---


       Jeffrey Pompeo       21,019,592    81.13    4,889,790           18.87

    ---


       Jean-Pierre Robert   21,213,336    81.88    4,696,046           18.12

    ---


       Linda Rosentstock    21,714,350    83.81    4,195,032           16.19

    ---


       Richard M. Rumble    20,395,438    78.72    5,513,944           21.28

    ---


       Steve West           21,692,971    83.73    4,216,411           16.27

    ---

Other Proposals

                       
      Votes for 
     % for  
     Withheld   
     % withheld


       Proposals

    ---

        Appointment of
         Independent
         Auditors        27,794,707    87.17    4,089,764           12.83

    ---

Final voting results on all matters voted at the Annual Meeting of Shareholders held on May 7, 2019, will be filed on SEDAR (www.sedar.com) under the name TSO(3).

About TSO(3)

Founded in 1998, TSO(3)'s activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. TSO(3) also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.

For more information about TSO(3), visit the Company's website at www.tso3.com.

View original content:http://www.prnewswire.com/news-releases/tso3-announces-the-vote-results-from-its-annual-meeting-of-the-shareholders-300846418.html

SOURCE TSO3 Inc.